MSL
ENZ

Mackay Shields LLC’s Enzo Biochem, Inc. ENZ Stock Holding History

Mackay Shields LLC’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,900
Closed -$38K – 1523
2019
Q1 		$38K Buy
+13,900
New +$45.5K ﹤0.01% 1372

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mackay Shields LLC's ENZ Position: Q2 2019 in Review

Mackay Shields LLC sold out of Enzo Biochem, Inc. (ENZ) in Q2 2019, closing a stake of 13,900 shares — an estimated $38K sold.

Mackay Shields LLC first reported a position in ENZ in Q1 2019 and held it in 1 quarter. The position peaked at $38K in Q1 2019. 95 funds tracked by Wall St. Rank hold ENZ as of Q2 2019.

  • Mackay Shields LLC reported no remaining Enzo Biochem, Inc. position as of Q2 2019 after selling out during the quarter.
  • Mackay Shields LLC sold 13,900 Enzo Biochem, Inc. shares in Q2 2019, an estimated $38K.
  • Mackay Shields LLC first reported a position in Enzo Biochem, Inc. in Q1 2019 and held it in 1 quarter.
  • Mackay Shields LLC's Enzo Biochem, Inc. position peaked at $38K in Q1 2019.
  • 95 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2019.

Based on Mackay Shields LLC's 13F filing for Q2 2019, filed 13 Aug 2019.